Three different expression patterns of T-bet in angioimmunoblastic T-cell lymphoma

References

• Frizzera G, Moran EM, Rappaport H. Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course. Am J Med 1975;59: 803–818.
   PubMed Web of Science ®Google Scholar
• Lukes RJ, Tindle BH. Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease. N Engl J Med 1975; 292:1–8.
   PubMed Web of Science ®Google Scholar
• Alizadeh AA, Advani RH. Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategies. Clin Adv Hematol Oncol 2008;6:899–909.
   PubMedGoogle Scholar
• Dogan A, Attygalle AD, Kyriakou C. Angioimmunoblastic T-cell lymphoma. Br J Haematol 2003;121:681–691.
   PubMed Web of Science ®Google Scholar
• Sallah S, Gagnon GA. Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment. Acta Haematol 1998;99:57–64.
   PubMed Web of Science ®Google Scholar
• Attygalle AD, Kyriakou C, Dupuis J, . Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 2007;31:1077–1088.
   PubMed Web of Science ®Google Scholar
• Attygalle AD, Chuang SS, Diss TC, . Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics. Histopathology 2007;50:498–508.
   PubMed Web of Science ®Google Scholar
• Dorfman DM, van den Elzen P, Weng AP, . Differential expression of T-bet, a T-box transcription factor required for Th1 T-cell development, in peripheral T-cell lymphomas. Am J Clin Pathol 2003;120:866–873.
   PubMed Web of Science ®Google Scholar
• Grogg KL, Attygalle AD, Macon WR, . Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol 2006;19:1101–1107.
   PubMed Web of Science ®Google Scholar
• Yu H, Shahsafaei A, Dorfman, DM. Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma. Am J Clin Pathol 2008;131:33–41.
   Web of Science ®Google Scholar
• De Leval L, Rickman DS, Thielen C, . The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T cells (TFH). Blood 2007;109:4952–4963.
   PubMed Web of Science ®Google Scholar
• Gerth AJ, Lin L, Peng SL. T-bet regulates T-independent IgG2a class switching. Int Immunol 2003;15:937–944.
   PubMed Web of Science ®Google Scholar
• Szabo SJ, Kim ST, Costa GL, . A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000;100:655–669.
   PubMed Web of Science ®Google Scholar
• Szabo SJ, Sullivan BM, Stemmann C, . Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002;295:338–342.
   PubMed Web of Science ®Google Scholar
• Finotto S, Neurath MF, Glickman JN, . Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002;295:336–338.
   PubMed Web of Science ®Google Scholar
• Peng SL, Szabo SJ, Glimcher LH. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc Natl Acad Sci USA 2002;99:5545–5550.
   PubMed Web of Science ®Google Scholar
• Peng SL, Li J, Lin L, . The role of T-bet in B cells. Nat Immunol 2003;4:1041; author reply 1041.
   PubMed Web of Science ®Google Scholar
• Gocke AR, Cravens PD, Ben LH, . T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J Immunol 2007;178: 1341–1348.
   PubMed Web of Science ®Google Scholar
• Yang Y, Weiner J, Liu Y, . T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J Exp Med 2009;206:1549–1564.
   PubMed Web of Science ®Google Scholar
• Yang Y, Xu J, Niu Y, . T-bet and eomesodermin play critical roles in directing T cell differentiation to Th1 versus Th17. J Immunol 2008; 181:8700–8710.
   Google Scholar
• Dupuis J, Boye K, Martin N, . Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 2006;30:490–494.
   PubMed Web of Science ®Google Scholar
• Zhao WL, Mourah S, Mounier N, . Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression. Lab Invest 2004;84:1512–1519.
   PubMed Web of Science ®Google Scholar
• Kim YS, Hong SW, Choi JP, . Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways. J Immunol 2009;183:5113–5120.
   PubMed Web of Science ®Google Scholar
• Kim YS, Choi SJ, Tae YM, . Distinct roles of vascular endothelial growth factor receptor-1- and receptor-2-mediated signaling in T cell priming and Th17 polarization to lipopolysaccharide-containing allergens in the lung. J Immunol 2010;185:5648–5655.
   PubMed Web of Science ®Google Scholar
• Takagi R, Higashi T, Hashimoto K, . B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones. J Immunol 2008;181:186–189.
   PubMed Web of Science ®Google Scholar
• Bending D, Newland S, Krejci A, . Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells. J Immunol 2011;186:3373–3382.
   PubMed Web of Science ®Google Scholar
• Cobb D, Hambright D, Smeltz RB. T-bet-independent effects of IL-12 family cytokines on regulation of Th17 responses to experimental T. cruzi infection. J Leukoc Biol 2010;88:965–971.
   Google Scholar
• Tripodo C, Gri G, Piccaluga PP, . Mast cells and Th17 cells contribute to the lymphoma-associated proinflammatory microenvironment of angioimmunoblastic T-cell lymphoma. Am J Pathol 2010;177:792–802.
   PubMed Web of Science ®Google Scholar
• Gullick NJ, Evans HG, Church LD, . Linking power Doppler ultrasound to the presence of Th17 cells in the rheumatoid arthritis joint. PLoS One 2010;5.
   Google Scholar
• Meeuwisse CM, van der Linden MP, Rullmann TA, . Identification of CXCL13 as marker for outcome of rheumatoid arthritis using an in silico model of the rheumatic joint. Arthritis Rheum 2011;63:1265–1273.
   PubMed Web of Science ®Google Scholar
• Bruneau J, Canioni D, Renand A, . Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma. Am J Pathol 2010;177:570–574.
   PubMed Web of Science ®Google Scholar